Exelixis reported $28.47M in Stock for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acadia Pharmaceuticals ACAD:US $ 7.01M 0.87M
Akebia Therapeutics AKBA:US $ 39.42M 1.23M
Amgen AMGN:US $ 4411M 325M
Bayer BAYN:GR € 11314M 670M
Biomarin Pharmaceutical BMRN:US $ 786.36M 9.69M
Eisai 4523:JP Y 99008M 6497M
Esperion Therapeutics ESPR:US $ 35.65M 1.26M
Exelixis EXEL:US $ 28.47M 0.97M
Merk MRK:US $ 5774M 179M
Nektar Therapeutics NKTR:US $ 15.8M 0.47M
Novartis NOVN:VX SF 6997M 331M
Takeda 4502:JP Y 853167M 41843M
Ultragenyx Pharmaceutical RARE:US $ 17.81M 1.58M